Diretrizes

Diretriz | Abordagem clínica de adultos com COVID-19 fora da UTI.

2 Ago, 2021 | 19:13h

Clinical Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP) – Infectious Diseases and Therapy

---

Diretriz Científica AHA | Doença arterial periférica em membro inferior: epidemiologia, tratamento e direções futuras.

2 Ago, 2021 | 19:02h

Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions: A Scientific Statement From the American Heart Association – Circulation

Itens principais a saber: Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions – American Heart Association

Comentário: The Need for Improved Identification and Treatment of Peripheral Arterial Disease – American Heart Association

---

Diretriz de prática clínica para o tratamento de volvo colônico e pseudo-obstrução colônica aguda.

2 Ago, 2021 | 18:59h

The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Colonic Volvulus and Acute Colonic Pseudo-Obstruction – Diseases of the Colon & Rectum

Comunicado de imprensa: American Society of Colon & Rectal Surgeons Publishes New Guidelines for Colonic Volvulus and Acute Colonic Pseudo-Obstruction

---

Resumo de diretriz | Rastreamento de efeitos tóxicos na retina de pacientes em uso de antimaláricos.

2 Ago, 2021 | 18:46h

A Multidisciplinary Collaborative Approach to Retinal Toxic Effects Screening for Dermatology Patients Taking Antimalarials – JAMA Dermatology (gratuito por tempo limitado)

Diretriz original: Joint Statement: Hydroxychloroquine use with respect to retinal toxicity

---

Recomendações para seguimento do European PanCare para a vigilância de efeitos tardios do câncer na criança, no adolescente e no adulto jovem.

2 Ago, 2021 | 18:44h

European PanCare Follow Up Recommendations for surveillance of late effects of childhood, adolescent, and young adult cancer – European Journal of Cancer

---

Diretriz rápida NICE COVID-19 | Trombocitopenia trombótica imune induzida por vacina.

2 Ago, 2021 | 18:37h

COVID-19 rapid guideline: vaccine-induced immune thrombocytopenia and thrombosis – National Institute for Health and Care Excellence

Comunicado de imprensa: NICE publishes new rapid guideline to diagnose and treat rare blood clotting condition associated with COVID-19 vaccination – National Institute for Health and Care Excellence

Conteúdo relacionado: Very rare cases of thrombosis with thrombocytopenia syndrome (TTS) after AstraZeneca vaccine: a global safety database analysis – the estimated rate of TTS after the first dose was 8.1 per million vaccinees; after the second dose, the estimated rate was 2.3 per million vaccinees. (vários artigos e fontes sobre o tema)

---

Diretrizes brasileiras sobre angina instável e infarto agudo do miocárdio sem elevação do segmento ST – 2021.

2 Ago, 2021 | 18:15h

Brazilian Society of Cardiology Guidelines on Unstable Angina and Acute Myocardial Infarction without ST-Segment Elevation – 2021 – Arquivos Brasileiros de Cardiologia (PDF)

---

Telessaúde em oncologia: recomendações práticas da ASCO.

2 Ago, 2021 | 18:13h

Telehealth in Oncology: ASCO Standards and Practice Recommendations – JCO Oncology Practice

---

Diretriz atualizada da ASCO | Tratamento endocrinológico e terapia-alvo para câncer de mama metastático positivo para receptor hormonal e negativo para receptor do fator de crescimento epidermal humano 2.

2 Ago, 2021 | 18:11h

Endocrine Treatment and Targeted Therapy for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer: ASCO Guideline Update – Journal of Clinical Oncology

---

Abordagem axilar no estágio inicial do câncer de mama: Ontario Health (Cancer Care Ontario) e Diretriz ASCO.

2 Ago, 2021 | 18:09h

Management of the Axilla in Early-Stage Breast Cancer: Ontario Health (Cancer Care Ontario) and ASCO Guideline – Journal of Clinical Oncology

---